Dergiler / Marmara Pharmaceutical Journal / 2017 / Cilt: 21 - Sayı: 1

Determination of haloperidol drug in ampoules and in urine samples using a potentiometric PVC-membrane and graphite coated wire electrodes

Sayfa
110–120
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The proposed electrodes were successfully used for determination of HP drug in ampoules and in urine samples with satisfactory results.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:A new PVC membrane, called sensor P, and graphite coated wire, called sensor g, for haloperidol drug (HP) are described.
📊
Temel Bulgular & Veri:The electrodes P and C exhibit a nernstian slope of 57.4±0.8 and 61.1±0.4 mV per decade over a wide concentration range from 3.7×10-6–1.0×10-2 mol/l and 5.8 x 10-7 – 1.0 x 10-2 mol/l and the limit of detection (loD) of 1.6 × 10-6 mol/l and 4.2×10-7 mol/l over the pH range of 2.5–7.5 and 2.5-8.0 respectively.
💡
Sonuç & Katkı:The proposed electrodes were successfully used for determination of HP drug in ampoules and in urine samples with satisfactory results.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

A new PVC membrane, called sensor P, and graphite coated wire, called sensor g, for haloperidol drug (HP) are described. The electrodes P and C exhibit a nernstian slope of 57.4±0.8 and 61.1±0.4 mV per decade over a wide concentration range from 3.7×10-6–1.0×10-2 mol/l and 5.8 x 10-7 – 1.0 x 10-2 mol/l and the limit of detection (loD) of 1.6 × 10-6 mol/l and 4.2×10-7 mol/l over the pH range of 2.5–7.5 and 2.5-8.0 respectively. The presented sensors show a very good selectivity for HP drug over the common interfering chemical species. The proposed electrodes were successfully used for determination of HP drug in ampoules and in urine samples with satisfactory results.

🔖

Bu Makaleye Atıf Yap

SHAWiSH, H. M. A., TAMOUS, H., SHAHEEN, A. A., ALMONEM, K. I. A., ELGAMEL, A. A., AL-LHAM, W. S. (2017). Determination of haloperidol drug in ampoules and in urine samples using a potentiometric PVC-membrane and graphite coated wire electrodes. Marmara Pharmaceutical Journal, Cilt: 21 - Sayı: 1, 110–120. https://ajindex.com/articles/283678

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (6)

  1. Faller Dv. endothelial cell responses to hypoxic stress. Clin exp Pharmacol Physiol 1999; 26: 74-84. Carlson JT, rangemark C, Hedner Ja. attenuated endothelium dependent vascular relaxation in patients with sleep apnea. J Hypertens 1996; 14: 577-84. Tetik Ş, ak k. kardiyovasküler hastalıklarda trombosit fonksiyon testleri: patofizyolojiden klinik yaklaşıma. Cumhuriyet Med J 2010; 32: 264-74.
  2. Chen C, Halkos Me, Surowiec SM, Conklin BS, Lin PH, Lumsden aB. effects of homocysteine on smooth muscle cell proliferation in both cell culture and artery perfusion culture models. J Surg res 2000;88:26-33. klein I, Ojamaa k. Thyroid hormone and the cardiovascular system. n engl J Med 2001;344:501-9.
  3. Toft aD, Boon na. Thyroid disease and the heart. Heart 2000;84:455-60.
  4. Yuvanç U, Çiçek D, Yeşilbursa D, karaağaç k, Şentürk T, Siğirli D, Jordan J. akut miyokard infarktüsünde ortalama trombosit hacminin bir yıllık mortalite ve revaskülarizasyon ihtiyacı üzerine etkisi. Mn-kardiyoloji Derg 2004;11:416-20.
  5. Wallentin L, Lindahl B, Siegbahn a. Unstable angina and non ST-elevation MI. In: Cardiology, 1st ed. editors: Crawford MH, DiMarco JP, Paulus WJUSa. elsevier Science Limited. 2001. Tetik Ş, ak k, Yardımcı kT. Trombosit fonksiyon testlerini etkileyen faktörler. Cumhuriyet Med J 2012; 34:123-7.
  6. Sokolow M, Mcilory Me. Clinical cardiology, second edition. WB Saunders Com., new York. 1979, pp 124. Helgeland a, Hjermann I, Leren P, enger S, Holme I. HDL cholesterol and antihypertensive drugs: the Oslo Study. Br Med J 1978;2:403. Third report of the national Cholesterol education Program (nCeP) expert Panel on Detection, evaluation, and Treatment of High Blood Cholesterol in adults (adult Treatment Panel III) final report. Circulation 2002;106:3143-421. roger vL, Go aS, Lloyd-Jones DM, Benjamin eJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford eS, Fox CS, Fullerton HJ, Gillespie C, Hailpern SM, Heit Ja, Howard vJ, kissela BM, kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli a, Matchar DB, Moy CS, Mozaffarian D, Mussolino Me, nichol G, Paynter nP, Soliman eZ, Sorlie PD, Sotoodehnia n, Turan Tn, virani SS, Wong nD, Woo D, Turner MB; american Heart association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics--2012 update: a report from the american Heart association. Circulation 2012;125:188-97. erratum in Circulation 2012;125:e1001. assmann, G. Dabetic Dyslipidaemia results From the Prospective Cardiovascul